Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Org Chem ; 82(23): 12715-12725, 2017 12 01.
Article in English | MEDLINE | ID: mdl-29124923

ABSTRACT

A palladium-catalyzed decarboxylative ortho-acylation of tertiary benzamides with α-oxocarboxylic acids by weak O-coordination has been described. This reaction proceeds smoothly with a high monoacylation selectivity, affording ortho-acylated benzamides in moderate to good yields. When secondary benzamides are employed as the substrates, the formed ortho-acylated benzamides undergo further intramolecular cyclization to provide isoindolinone derivatives. In addition, several transformations of the synthesized ortho-acylated benzamides into a diversity of synthetically valuable products have been demonstrated.

2.
Arch Pharm (Weinheim) ; 344(2): 78-83, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21290423

ABSTRACT

Recently, heterocyclic benzimidazole derivatives have been investigated and validated as a promising class of antiviral agents. In this paper, a series of novel thiazolylbenzimidazole derivatives was synthesized and evaluated for their anti-hepatitis B virus (HBV) activity and cytotoxicity on the HepG2.2.15 cell line. Afterwards, the preliminary structure-activity relationship (SAR) was discussed. Compound 8b, with IC(50) = 1.1 µM and SI > 90.9, was the most promising compound and could be selected as a benchmark compound for further investigation.


Subject(s)
Antiviral Agents/chemical synthesis , Antiviral Agents/pharmacology , Benzimidazoles/chemical synthesis , Benzimidazoles/pharmacology , Hepatitis B virus/drug effects , Antiviral Agents/chemistry , Antiviral Agents/toxicity , Benzimidazoles/chemistry , Benzimidazoles/toxicity , Cell Death/drug effects , Drug Screening Assays, Antitumor/methods , Hep G2 Cells/drug effects , Humans , Inhibitory Concentration 50 , Microbial Sensitivity Tests/methods , Molecular Structure , Structure-Activity Relationship
3.
Bioorg Med Chem ; 18(14): 5048-55, 2010 Jul 15.
Article in English | MEDLINE | ID: mdl-20639110

ABSTRACT

A series of novel benzimidazole derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activity and cytotoxicity in the HepG2.2.15 cell line. The preliminary SAR was discussed. Compound 12a, with IC50<0.41 microM and SI>81.2, was the most promising compound and selected as the benchmark compound for further optimization.


Subject(s)
Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Benzimidazoles/chemistry , Benzimidazoles/pharmacology , Hepatitis B virus/drug effects , Hepatitis B/drug therapy , Antiviral Agents/chemical synthesis , Benzimidazoles/chemical synthesis , Cell Line, Tumor , Cell Survival/drug effects , Humans , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...